0001567619-18-004313.txt : 20181018 0001567619-18-004313.hdr.sgml : 20181018 20181018172248 ACCESSION NUMBER: 0001567619-18-004313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180515 FILED AS OF DATE: 20181018 DATE AS OF CHANGE: 20181018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moscato Robert Jr. CENTRAL INDEX KEY: 0001723420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 181128938 MAIL ADDRESS: STREET 1: 400 PRATT STREET STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LRS International, LLC CENTRAL INDEX KEY: 0001756192 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 181128939 BUSINESS ADDRESS: STREET 1: 9116 WINGED THISTLE COURT CITY: RALEIGH STATE: NC ZIP: 27617 BUSINESS PHONE: 919-345-5544 MAIL ADDRESS: STREET 1: 9116 WINGED THISTLE COURT CITY: RALEIGH STATE: NC ZIP: 27617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerecor Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 E. PRATT ST. STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 400 E. PRATT ST. STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 4 1 doc1.xml FORM 4 X0306 4 2018-05-15 1 0001534120 Cerecor Inc. CERC 0001723420 Moscato Robert Jr. 9116 WINGED THISTLE COURT RALEIGH NC 27617 0 0 1 0 0001756192 LRS International, LLC 9116 WINGED THISTLE COURT RALEIGH NC 27617 0 0 1 0 On September 24, 2018, the Issuer entered into and subsequently consummated the transactions contemplated by an Agreement and Plan of Merger among the Issuer, ITX Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, Second ITX Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer, Ichorion Therapeutics, Inc., a Delaware Corporation ("Ichorion"), and a Holders' Representative, providing for the merger of Ichorion with the Issuer, with Ichorion surviving as a wholly owned subsidiary of the Issuer. The consideration for the Merger at closing consisted of 5,798,735 shares of the Issuer's Common Stock, par value $0.001 per share (the "Merger Shares"), as adjusted for Estimated Working Capital. As a result of the Issuer's issuance of the Merger Shares, the Reporting Persons' beneficial ownership of the Issuer is now below 10%, and the Reporting Persons are no longer subject to Section 16. /s/ Robert Moscato, Jr 2018-10-17 /s/ LRS International, LLC, by Robert Moscato, Jr. 2018-10-17